|
Welcome to the CMH Foundation Learning Center. You may choose a variety of learning programs presented in several downloadable formats.
 |
|
|
ACE Inhibitors for Reducing Global CV Risk
Evidence Against a Class Effect
This bulletin reviews data from trials that evaluated treatment options for
patients with both hypertension and other risk factors for CV disease.
|
|
|
|
|
|
|
|
Hypertension and Stroke Prevention
Listen to Henry Black, MD, highlight the importance of treating hypertension and
its relationship to stroke prevention. |
|
|
|
|
|
|
|
Ambulatory BP Monitoring in Clinical Practice
Listen to William White, MD, explain the benefits of measuring 24-hour
ambulatory blood pressure, including the elimination of the "white coat" effect
and the discovery of masked hypertension. |
|
|
|
|
|
|
|
Clinical Management of Hypertensive Heart Disease:
Preventing Heart Failure
Listen to Clyde Yancy, MD, discuss the relationship between treating hypertension and associated risk factors and preventing heart failure. |
|
|
|
|
|
|
|
Prehypertension as a Predictor of Hypertension
Listen to L. Michael Prisant, MD, discuss the latest blood pressure values of the JNC 7, including the Prehypertension classification and its association with increased cardiovascular risk. |
|
|
|
|
|
|
|
Managing Hypertension and Associated Risk Factors Among African American Women
Listen to Keith Ferdinand, MD, discuss the specific considerations for treating
hypertension and managing cardiovascular risk in African American women. |
|
|
|
|
|
|
|
Signs Along the Risky Road to CHD
A unique, online, case-based needs assessment survey that will provide some
interesting insights into a patient whose coronary risk profile is worsening. |
|
|
|
|
|
|
|
Teleconference On Demand With Terry Jacobson, MD:
Residual Cardiovascular Risk
Risk Reduction Through Aggressive Management of Triglycerides and HDL-C |
 |
|
|
|
|
|
|
Managing Hemostasis in an Era of Conventional and Novel Anticoagulants
Jerrold H. Levy, MD, FAHA, offers insights on conventional and novel anticoagulants and the challenges they pose for clinicians who must manage the hemostatic stability of their patients in emergent situations.
|
|
|
|
|
|
|
|
Drug-Induced Thrombocytopenia: New Options and Treatment Strategies
Patricia A. Ford, MD, explores the pathogenesis of drug-induced thrombocytopenia and the diagnostic challenges it presents to clinicians.
|
|
|
|
|
|
|
|
Challenges in Perioperative Hemostasis: Managing Coagulopathy in Elective and Urgent Cardiac Surgery
Listen to Ian J. Welsby, MD, MBBS, FRCA, and Peter K. Smith, MD, discuss the essential aspects of hemostasis, as well as current and emerging therapeutic options for restoring hemostasis in cardiac surgery patients. |
|
|
|
|
|
|
|
Q&A: Challenges in Perioperative Hemostasis: Managing Coagulopathy in Elective and Urgent Cardiac Surgery
Listen to Ian J. Welsby, MD, MBBS, FRCA, and Peter K. Smith, MD, exchange views on the challenges involved in managing coagulopathy in cardiac surgery from the perspective of an anesthesiologist and a surgeon. |
|
|
|
|
|
|
|
Current Trends in Coagulation: The Correlation Between Fibrinogen Levels and Surgical Hemostasis
Listen to Aryeh Shander, MD, FCCM, FCCP, discuss the role of plasma fibrinogen in perioperative hemostasis and strategies for maintaining optimal hemostasis in cardiothoracic surgery. |
|
|
|
|
|
|
|
Clinical Perspectives: When Fibrinogen Deficiency Complicates Surgical Hemostasis
How do you improve clinical outcome in patients with a decreased plasma fibrinogen level caused by excessive bleeding?
Anesthesiologist Mark Ereth addresses the challenges posed by fibrinogen deficiency resulting from excessive bleeding in
cardiac surgery patients and available therapies for correcting deficits of this key coagulation factor to achieve perioperative
hemostasis.
|
|
|
|
|
|
|
|
Pressing Issues About Preoperative Anemia
In this Q&A interview, Aryeh Shander, MD, FCCM, FCCP, discusses the challenges that preoperative anemia presents to surgical team members and other clinicians.
|
|
|
|
|
|
|
|
